PGR and breast carcinoma: Six breast cancer datasets were also used to test the robustness of the progesterone receptor (PGR) signature (Anders et al., 2008; Chin et al., 2006; Finak et al., 2008; Huang et al., 2003; The Cancer Genome Atlas Network, 2012).